CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.46B, above the global median of $1.18B
- FinancialsAltman Z-Score 3.44: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.54%
Annual Rate
CNY 0.15Paid annual
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jul 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.80BCNY1.46B · vs all stocks (USD)
Trailing P/E
70.03xRevenue (TTM)
1.68BCNY251.56M · vs all stocks (USD)
Profit Margin
6.94%Beta
-0.1680xvs all stocks
52-Week Change
83.99%vs all stocks
Market Capitalization
9.80BCNY1.46B · vs all stocks (USD)
Enterprise Value
9.28BCNY1.39B · vs all stocks (USD)
Trailing P/E
70.03xForward P/E
18.74xPrice to Sales (TTM)
5.37xPrice to Book (MRQ)
3.08xEnterprise to Revenue
5.51xEnterprise to EBITDA
29.26xGross Margin
30.67%Profit Margin
6.94%Operating Margin
13.36%Return on Assets (TTM)
2.43%Return on Equity (TTM)
4.41%Revenue (TTM)
1.68BCNY251.56M · vs all stocks (USD)
Revenue per Share (TTM)
5.37CNYUpdated Sep 22, 2026Quarterly Revenue Growth
30.00%Gross Profit (TTM)
525.10MCNY78.41M · vs all stocks (USD)
EBITDA (TTM)
208.94MCNY31.20M · vs all stocks (USD)
Net Income (TTM)
116.86MCNY17.45M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
16.90%Operating Cash Flow (TTM)
189.73MCNY28.33M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-264.44MCNY-39.49M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1550CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.54%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
115.17MCNYFY2025 · Dec 31, 2025Revenue
1.50BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
976.42MCNYFY2025 · Dec 31, 2025Gross Profit
526.71MCNYFY2025 · Dec 31, 2025Operating Income
200.71MCNY29.97M · vs all stocks (USD)
Pre-tax Income
129.78MCNYFY2025 · Dec 31, 2025Income Tax Expense
23.66MCNYFY2025 · Dec 31, 2025Net Income
106.12MCNYFY2025 · Dec 31, 2025EBIT
171.61MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
345.11MCNYFY2025 · Dec 31, 2025Research & Development
109.35MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
100.19MCNYFY2025 · Dec 31, 2025Other Operating Expenses
18.40MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
11.52MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
41.83MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3429CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3357CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
298.17MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
298.17MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
106.12MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-3.89MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
60.55MCNYFY2025 · Dec 31, 2025Free Cash Flow
-33.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
476.09MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
106.12MCNYFY2025 · Dec 31, 2025Other Non-cash Items
45.70MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
20.23MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-111.50MCNYFY2025 · Dec 31, 2025Capital Expenditures
-93.65MCNYFY2025 · Dec 31, 2025Purchase of Investments
-358.15MCNYFY2025 · Dec 31, 2025Sale of Investments
349.31MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-102.50MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.09BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-955.26MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-25.89MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.50MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
101.72MCNYFY2025 · Dec 31, 2025Shares Outstanding
339.93MSharesUpdated Sep 22, 2026Float Shares
253.94MSharesUpdated Sep 22, 2026% Held by Insiders
29.51%vs all stocks
% Held by Institutions
3.23%vs all stocks
Total Cash (MRQ)
642.90MCNY96.00M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.89CNYUpdated Sep 22, 2026Total Debt (MRQ)
779.87MCNY116.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2577xCurrent Ratio (MRQ)
1.43xBook Value per Share (MRQ)
8.63CNYUpdated Sep 22, 2026Total Assets
4.85BCNY724.61M · vs all stocks (USD)
Total Current Assets
2.28BCNYFY2025 · Dec 31, 2025Total Liabilities
2.40BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.57BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
817.25MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.58BCNYFY2025 · Dec 31, 2025Cash
516.99MCNYFY2025 · Dec 31, 2025Cash Equivalents
184.68MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
701.67MCNYFY2025 · Dec 31, 2025Other Short-term Investments
216.82MCNYFY2025 · Dec 31, 2025Accounts Receivable
364.75MCNYFY2025 · Dec 31, 2025Inventory
858.72MCNYFY2025 · Dec 31, 2025Accounts Payable
511.51MCNYFY2025 · Dec 31, 2025Short-term Debt
813.01MCNYFY2025 · Dec 31, 2025Other Current Liabilities
4.16MCNYFY2025 · Dec 31, 2025Long-term Debt
689.74MCNYFY2025 · Dec 31, 2025Common Stock (Book)
220.63MCNYFY2025 · Dec 31, 2025Retained Earnings
1.36BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.45BCNY365.99M · vs all stocks (USD)
Treasury Stock
28.92MCNYFY2025 · Dec 31, 202552-Week Low
13.55CNYUpdated Sep 22, 202652-Week High
50.28CNYUpdated Sep 22, 202652-Week Change
83.99%vs all stocks
Beta
-0.1680xvs all stocks
50-Day MA
28.56CNYUpdated Sep 22, 2026200-Day MA
25.55CNYUpdated Sep 22, 2026Avg 10-Day Volume
30.47MSharesUpdated Sep 22, 2026Avg 30-Day Volume
50.71MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.3800CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.44: safe zoneNotable
Altman Z-Score: 3.44
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.46B, above the global median of $1.18BNotable
Market cap (USD): 1,462,945,747.347Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Mayinglong Pharmaceutical Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Inhibrx Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Taienkang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Omeros Corporation
Tier 1ProductionApproval-Gated PipelineRuleRisk
Classys Inc.
Tier 1ProductionApproval-Gated PipelineRule
Concord Biotech Ltd.
Tier 1ProductionApproval-Gated PipelineRule
D&D Pharmatech Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Aurora Optoelectronics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlow
Maze Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
HBM Holdings Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Hyosung Heavy Industries Corporation
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Guizhou Red Star Developing Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Longhua Technology Group Luoyang Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated